Concepedia

Loïc Foulon

LF

2

Publications

301

Citations

2

H-Index

1996

Active since

Affiliations

Sanofi (France)(Current)

Loïc Foulon is an author at Sanofi (France) specializing in medicine, drug discovery, and molecular pharmacology.

Top concepts

Publications per year

1996–2004

2

Publications

2

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 247 citations · Full text

, , +14

SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor

Claudine Serradeil‐Le Gal, Gérard Valette, Loïc Foulon et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 54 citations

Rows per page

1–2 of 2